Last reviewed · How we verify

AZD5462 film-coated tablet

AstraZeneca · Phase 1 active Small molecule Quality 0/100

AZD5462 film-coated tablet is a Small molecule drug developed by AstraZeneca. It is currently in Phase 1 development. Also known as: AZD5462.

At a glance

Generic nameAZD5462 film-coated tablet
Also known asAZD5462
SponsorAstraZeneca
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about AZD5462 film-coated tablet

What is AZD5462 film-coated tablet?

AZD5462 film-coated tablet is a Small molecule drug developed by AstraZeneca.

Who makes AZD5462 film-coated tablet?

AZD5462 film-coated tablet is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).

Is AZD5462 film-coated tablet also known as anything else?

AZD5462 film-coated tablet is also known as AZD5462.

What development phase is AZD5462 film-coated tablet in?

AZD5462 film-coated tablet is in Phase 1.

Related